Philips Led HYPERImage Project Advances Research on Hybrid PET/MR Scanner

Royal Philips ElectronicsAs leader of the European Union funded HYPERImage research project, Royal Philips Electronics (NYSE: PHG, AEX: PHI) announced that the project has achieved a major milestone in its ambitious plan to create a new medical imaging technique called hybrid PET/MR. This new technique is based on the simultaneous acquisition of time-of-flight Positron Emission Tomography (PET) and Magnetic Resonance (MR) images.

The project involves eight partners from six European countries and has a total budget of around EUR 7 million. The ultimate goals of the project are to advance the accuracy of diagnostic imaging in cardiology and oncology and open up new fields in therapy planning, guidance and response monitoring.

A hybrid PET/MR scanner could simultaneously deliver the anatomical and functional information achievable using state-of-the-art MR scanners (e.g. soft tissue contrast and physiological processes in blood vessels) and the molecular imaging information provided by PET. As a result, it would combine the best of both worlds, which could ultimately help to pinpoint and characterize disease sites within the body more accurately than is currently possible.

For a hybrid scanner that offers simultaneous PET and MR image acquisition, two fundamental problems need to be solved: the development of MR-compatible PET detectors and a method of accounting for PET attenuation (the scattering of high-energy gamma rays generated by the PET tracers by parts of the human body).

The milestone that the HYPERImage team has reached is the development of a functional gamma-ray detector that meets the performance requirements of the latest time-of-flight PET scanners. The new gamma-ray detectors have been designed to be compatible with the strong static and dynamic magnetic fields that would be present in a combined PET/MR scanner. Furthermore, the team has achieved major progress with respect to MRI-based static and dynamic PET attenuation correction. Details of these results are presented at the IEEE Nuclear Science Symposium and Medical Imaging Conference, which takes place on October 25-31 in Orlando, Florida, USA.

"Understanding the molecular mechanisms associated with cardiovascular disease and cancer, and the development of technologies focused on the early detection of these disease processes are the two main challenges of biomedical research," said Prof. Dr. Valentin Fuster, Director of the National Center for Cardiovascular Research in Madrid (one of Europe's leading research centers in cardiology) and the Cardiovascular Institute at the Mount Sinai Medical Center in New York. "I am convinced that the realization of a PET/MR technology platform will significantly help to improve the precision and the moment at which disease is diagnosed, two critical parameters for the successful treatment of many diseases."

"The HYPERImage team’s combined expertise in semiconductor physics, signal processing and medical scanner design, together with its expert clinical knowledge, have moved the project an important step forward in the development of a new imaging tool that is intended to help clinicians diagnose and treat some of the world's most prevalent killer diseases, such as breast cancer," says Henk van Houten, senior vice president of Philips Research and head of Philips' healthcare research program. "I am proud to say that proof-of-concept of an MR-compatible PET detector took the team less than 1.5 years to achieve. It clearly demonstrates that good collaborations lead to very fast progress."

The HYPERImage consortium comprises three universities (King's College London, UK; Universität Heidelberg, Germany; and Universiteit Ghent - Institute for Broadband Technology, Belgium), three research foundations (Fundación Centro Nacional de Investigaciones Cardiovasculares, Spain; Fondazione Bruno Kessler, Italy; and The Netherlands Cancer Institute, The Netherlands), a university medical center (Uniklinikum Hamburg-Eppendorf, Germany) and the industrial partner (Philips, The Netherlands and Germany).

EU funding for the HYPERImage project, which is being provided as part of the EU's 7th Framework Program, amounts to around EUR 5 million. The consortium partners will provide an additional EUR 2.3 million. The project started in 2008 and will run for three years. Philips' leadership of the consortium is based on its experience in designing and developing medical scanners.

For further information, please visit:
http://www.hybrid-pet-mr.eu

Related news articles:

About Royal Philips Electronics
Royal Philips Electronics of the Netherlands (NYSE: PHG, AEX: PHI) is a diversified Health and Well-being company, focused on improving people’s lives through timely innovations. As a world leader in healthcare, lifestyle and lighting, Philips integrates technologies and design into people-centric solutions, based on fundamental customer insights and the brand promise of "sense and simplicity". Headquartered in the Netherlands, Philips employs more than 118,000 employees in more than 60 countries worldwide. With sales of EUR 26 billion in 2008, the company is a market leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as lifestyle products for personal well-being and pleasure with strong leadership positions in flat TV, male shaving and grooming, portable entertainment and oral healthcare. News from Philips is located at www.philips.com/newscenter.

Most Popular Now

AI Helps Physicians Better Assess the Ef…

In a small but multi-institutional study, an artificial intelligence (AI)-based system improved providers' assessments of whether patients with bladder cancer had complete response to chemotherapy before a radical cystectomy (bladder...

Smartwatches and Fitness Bands Reveal In…

A new digital health study by researchers at Scripps Research shows how data from wearable sensors, such as smartwatches and fitness bands, can track a person’s physiological response to the...

AI may Detect Earliest Signs of Pancreat…

An artificial intelligence (AI) tool developed by Cedars-Sinai investigators accurately predicted who would develop pancreatic cancer based on what their CT scan images looked like years prior to being diagnosed...

Open Call U4H-2022-PJ2: Call for Proposa…

The Ukraine crisis has an unprecedented impact on the mental health of the displaced people in the EU coming from Ukraine. The conflict and experiences of people in war zones...

AI Reduces Miss Rate of Precancerous Pol…

Artificial intelligence reduced by twofold the rate at which precancerous polyps were missed in colorectal cancer screening, reported a team of international researchers led by Mayo Clinic. The study is...

Medical Valley EMN & Volitan Global …

The two healthcare innovation experts Medical Valley EMN and Volitan Global strengthen their existing inbound- and outbound activities through a strategic partnership. The aim is to offer companies access to...

DMEA - Connecting Digital Health Opens w…

26 - 28 April 2022, Berlin, Germany. What plans does the new federal government have concerning the digital transformation of the healthcare sector? What are the initial experiences of doctors regarding...

AI can Predict Probability of COVID-19 v…

Testing shortages, long waits for results, and an over-taxed health care system have made headlines throughout the COVID-19 pandemic. These issues can be further exacerbated in small or rural communities...

Using AI to Detect Cancer from Patient D…

A new way of using artificial intelligence to predict cancer from patient data without putting personal information at risk has been developed by a team including University of Leeds medical...

Oulu University Hospital Expands Partner…

Siemens Healthineers and Oulu University Hospital in Finland have entered a strategic partnership for the next ten years, adding to an existing radiotherapy collaboration to jointly expand and modernize the...

Positive Conclusion to DMEA - Connecting…

26 - 28 April 2022, Berlin, Germany. After three days DMEA, Europe's leading digital health event, came to a successful conclusion - with around 11,000 visitors, more than 500 exhibitors and...

AI-Enabled ECGs may Identify Patients at…

Atrial fibrillation, the most common cardiac rhythm abnormality, has been linked to one-third of ischemic strokes, the most common type of stroke. But atrial fibrillation is underdiagnosed, partly because many...